Trial Phase definition

Trial Phase as defined in Policy on LFC&R Article B-10;
View Source

Examples of Trial Phase in a sentence

  • The SG CSO shall decide about the successful completion of the Trial Phase based on the evaluations provided by the regular report.

  • Trial Phase for Imbalance Netting, Cross-Border Activation of Reserves, Exchange of Reserves and Sharing of Reserves processes The relevant TSO involved in an Imbalance Netting Process, a cross-border aFRR Activation or mFRR Activation Process, a cross-border RR Activation Process, an exchange or sharing of Reserves between LFC Blocks within or between Synchronous Areas shall foresee a trial phase of at least one year.

  • In case where system security impact is detrimental, RG CE or SOC (in case of inter-Synchronous Area impacts) shall decide whether a Trial Phase shall be performed.

  • Trial Phase for Additional processes In case a Trial Phase for an Additional Process has been approved by the RG CE according to the Notification of Additional Processes, the SG CSO shall: report every three months to the RG CE evaluate the impact of the process on Operational Security at the end of the trial phase inform the RG CE about the final results and recommend a final decision to the RG CE.

  • For the first two Development Candidates to advance to a Phase I Clinical Trial, Phase I/II Clinical Trial, or Phase II Clinical Trial, subject to Section 4.1.3, Codiak will be responsible for the Development Costs of such Clinical Trials, including the cost of clinical supplies, up to the limit of [***] Dollars [***] per Development Candidate.

  • If a Milestone Event described above for any of Phase I Clinical Trial, Phase II Clinical Trial, or Phase III Clinical Trial is not achieved for a Product Candidate or Product, but one or more of subsequent Milestone Events described above for the same Product Candidate or Product is achieved, (e.g., approval is sought for example on a Phase II/III Clinical Trial), each such earlier skipped Milestone Payment will then be due and payable with and in addition to such subsequently achieved Milestone Payment.

  • Parent shall promptly (but no later than [***] ([***]) Business Days after Parent’s determination) notify the Stockholder Representative that any Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial of a Product was not Satisfactorily Completed and provide the Stockholder Representative a reasonable description of the basis for concluding that such clinical trial was not Satisfactorily Completed.

  • The Customer is aware and agrees that during the Free Trial Phase the Service may not be available, may be available only in a limited manner, may be available with significant interruptions and/or may be defective.

  • Unless otherwise agreed by the parties in writing, the Services shall include the non-Commercial supply of the Developed Product to BSC for the FHU Trial Phase.

  • As of the Effective Date of this Agreement, if not already terminated, the Trial Phase Agreement between ICERS and VENDOR dated September 23, 2008 (the "Trial Phase Agreement") is hereby terminated.

Related to Trial Phase

  • Development Phase means the period before a vehicle type is type approved.

  • Construction Phase means that Phase of the Project which shall commence after the Authority provides the Trade Contractor with written Notice to Proceed with the Construction Phase.

  • Phase 3 means a controlled or uncontrolled human clinical trial of a compound or product that would satisfy the requirements of 21 CFR 312.21(c) or its foreign equivalents.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.